JD Health International Inc.
JD Health International Inc.
Your view on JDHIY
Overview
What the company does, where it operates, and who runs it.
About JD Health International Inc.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Cao Dong
- Headquarters
- Jingdong Headquarters, Beijing, CN
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Cao Dong
- Headquarters
- Jingdong Headquarters, Beijing, CN
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China.
It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network.
The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services.
In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for JD Health International Inc., and the rating behind it. JDHIY last traded at $9.08, 16.1× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for JD Health International Inc.. Starting points for JD Health International Inc.: P/E 16.1, EPS $1.94, beta 1.19 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for JD Health International Inc.. JD Health International Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for JD Health International Inc.. Trailing twelve-month EPS for JD Health International Inc. stands at $1.94. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for JD Health International Inc.. JD Health International Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
JD Health International Inc. valued side by side against its closest peers. JD Health International Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold JD Health International Inc., and how their positions are changing. At a $29.07B market value, institutional positions materially move JD Health International Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by JD Health International Inc. executives and directors. Shares of JD Health International Inc. have traded between $3.81 and $9.08 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming JD Health International Inc.. JD Health International Inc. is a $29.07B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming JD Health International Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for JD Health International Inc.. Coverage tracks JD Health International Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.